New FDA Drug Security Program Targets Dubious Imports
Law360, New York (August 20, 2013, 4:08 PM EDT) -- The U.S. Food and Drug Administration will launch a program to stop contaminated, misbranded or unapproved medications from being imported into the country and is seeking applicants, including foreign makers of imported drugs, to participate, the agency said Tuesday.
The FDA's voluntary Secure Supply Chain Pilot Program — meant to ensure the safety of drugs made outside the U.S. — works by expediting the approval processes of qualified applicants to the program so that the agency can focus attention on drugs outside the program that may be more in need of scrutiny, according to a notice published in the Federal Register...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!